Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cancer Research Communications|December 19, 2024
Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene ExpressionDenis Ohlstrom, Zachary J Walker, Abhishek Pandey, et al.
Cancers|November 25, 2023
CD46-ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived XenograftsMichael J VanWyngarden, Zachary J Walker, Yang Su, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 21, 2017
Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive PatientsScott Ely, Peter Forsberg, Ihsane Ouansafi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two PracticesAmrita D Singh, Sapna Parmar, Khilna Patel, et al.
Leukemia & Lymphoma|March 1, 2014
Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myelomaTomer M Mark, Isaac A Bowman, Adriana C Rossi, et al.
Blood Advances|April 21, 2020
Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progressionZachary J Walker, Michael J VanWyngarden, Brett M Stevens, et al.
Cancer|November 6, 2018
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myelomaAjai Chari, Sagar Lonial, Tomer M Mark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2020
Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based TherapyZachary J Walker, Beau M Idler, Lorraine N Davis, et al.
Blood Advances|August 30, 2023
CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapiesOlivia Perez de Acha, Lauren Reiman, David S Jayabalan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2017
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple MyelomaTomer M Mark, Danielle Guarneri, Peter Forsberg, et al.
Pageof 5